207 related articles for article (PubMed ID: 6374968)
1. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
Hsieh SD; Akanuma Y; Takaku F
Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
[TBL] [Abstract][Full Text] [Related]
2. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
Hsieh SD; Kanazawa Y; Akanuma Y
Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
[TBL] [Abstract][Full Text] [Related]
3. Reduction of C-peptide secretion in noninsulin-dependent diabetic patients with long duration of insulin treatment.
Hsieh SD; Akanuma Y; Kawazu S; Mashiko S; Kanazawa Y; Iwamoto Y; Kikuchi M; Kosaka K
Endocrinol Jpn; 1983 Jun; 30(3):373-80. PubMed ID: 6363048
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
Miki H; Matsuyama T; Fujii S; Komatsu R; Nishioeda Y; Omae T
Diabetes Res Clin Pract; 1992 Nov; 18(2):99-105. PubMed ID: 1478158
[TBL] [Abstract][Full Text] [Related]
5. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum CPR to plasma glucose ratio with various indices of insulin secretion and diseases duration in type 2 diabetes.
Okuno Y; Sakaguchi K; Komada H; Hashimoto N; Hirota Y; Nakamura T; Ogawa W; Seino S
Kobe J Med Sci; 2013 Apr; 59(2):E44-53. PubMed ID: 23756662
[TBL] [Abstract][Full Text] [Related]
7. Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus.
Wakasaki H; Shono T; Nakao R; Yamamoto S; Minaga T; Fukuda S; Matsumoto R; Ohoshi T; Naka K; Nanjo K
Intern Med; 2020; 59(18):2229-2235. PubMed ID: 32938850
[TBL] [Abstract][Full Text] [Related]
8. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
Ubukata E
Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
[TBL] [Abstract][Full Text] [Related]
9. Glucose tolerance and insulin response in parents of patients with insulin-dependent and juvenile-onset non-insulin-dependent diabetes mellitus.
Matsuda A; Kuzuya T
Diabetes Res Clin Pract; 1992 Apr; 16(1):37-46. PubMed ID: 1576930
[TBL] [Abstract][Full Text] [Related]
10. Instability of fasting blood glucose values in noninsulin-dependent diabetic patients with long-term insulin treatment.
Hsieh SD; Akanuma Y
Metabolism; 1985 Apr; 34(4):371-6. PubMed ID: 3884966
[TBL] [Abstract][Full Text] [Related]
11. Blood lactate behavior after glucose load in diabetes mellitus.
Prando R; Cheli V; Buzzo P; Melga P; Ansaldi E; Accoto S
Acta Diabetol Lat; 1988; 25(3):247-56. PubMed ID: 3071066
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of low insulin responders to oral glucose load among groups with various patterns of family history of diabetes.
Matsuda A; Kuzuya T
Diabet Med; 1996 Sep; 13(9 Suppl 6):S59-62. PubMed ID: 8894484
[TBL] [Abstract][Full Text] [Related]
13. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
Amoah AG; Owusu SK; Schuster DP; Osei K
S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
[TBL] [Abstract][Full Text] [Related]
16. Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy.
Grant PJ; Barlow E; Miles DW
Diabet Med; 1984 Nov; 1(4):284-6. PubMed ID: 6242818
[TBL] [Abstract][Full Text] [Related]
17. Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency.
Sotaniemi EA; Karvonen I
Diabetes Res; 1989 Jul; 11(3):131-9. PubMed ID: 2697484
[TBL] [Abstract][Full Text] [Related]
18. Variation of fasting serum C-peptide level after admission in Japanese patients with type 2 diabetes mellitus.
Tajiri Y; Kimura M; Mimura K; Umeda F
Diabetes Technol Ther; 2009 Sep; 11(9):593-9. PubMed ID: 19764839
[TBL] [Abstract][Full Text] [Related]
19. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
Saisho Y; Kou K; Tanaka K; Abe T; Kurosawa H; Shimada A; Meguro S; Kawai T; Itoh H
Endocr J; 2011; 58(4):315-22. PubMed ID: 21415555
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control with an artificial pancreas improves insulin responses to both oral and glucose in nonobese noninsulin-dependent diabetic subjects.
Giugliano D; Di Pinto P; Ceriello A; Paolisso G; Saccomanno F; Torella R; D'Onofrio F
Acta Diabetol Lat; 1985; 22(3):203-13. PubMed ID: 3907235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
